UK Markets close in 26 mins

Xvivo Perfusion AB (publ) (0RKL.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
268.50-10.50 (-3.76%)
As of 05:27PM GMT. Market open.
Currency in SEK

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.68
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3279.00
52-week low 3267.50
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.4M
Implied shares outstanding 6N/A
Float 822.04M
% held by insiders 112.84%
% held by institutions 160.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -16.85%
Operating margin (ttm)-11.24%

Management effectiveness

Return on assets (ttm)-1.75%
Return on equity (ttm)-4.70%

Income statement

Revenue (ttm)220.6M
Revenue per share (ttm)7.81
Quarterly revenue growth (yoy)95.00%
Gross profit (ttm)132.97M
EBITDA -16.15M
Net income avi to common (ttm)-37.17M
Diluted EPS (ttm)-1.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)311.42M
Total cash per share (mrq)10.83
Total debt (mrq)5.79M
Total debt/equity (mrq)0.57
Current ratio (mrq)6.16
Book value per share (mrq)35.58

Cash flow statement

Operating cash flow (ttm)-26.92M
Levered free cash flow (ttm)-56.92M